||Jeffrey C. Bryan, PharmD
Clinical Pharmacy Specialist, Leukemia
The University of Texas MD Anderson Cancer Center
University of Texas College of Pharmacy
Adjunct Clinical Assistant Professor
University of Houston College of Pharmacy
|Dr. Bryan is a pharmacist and Preceptor in the Department of
Leukemia at the University of Texas MD Anderson Cancer Center. He received his
pharmacy degree in 2002 from the University of Georgia, Athens, Georgia. As a speaker, Dr. Bryan has given talks on pharmacy, multidisciplinary modalities, and leukemia therapies both in Houston and in Japan. He maintains an active interest in leukemia
during most of his research and clinical training with emphasis on experimental therapeutics. He has authored many chapters in current pharmacy textbooks. He has been published in many peer-reviewed journals. His main interest is myeloproliferative disorders.
Bachelors: Purdue University, West Lafayette, Indiana
Doctorate: Pharmacy, University of Georgia, College of Pharmacy, Athens, Georgia
Residency: Clinical Pharmacy, University of Alabama at Birmingham Hospital, Birmingham, Alabama
Fellowship: Hematology/Oncology Specialty, University of Alabama at Birmingham Hospital, Birmingham, Alabama
|Board Certification and Licensure
Medical License: Georgia, Alabama, and Texas
|Clinical and Research Interests
acute myelogenous leukemia (AML)
1: Bryan J, Kantarjian H, Garcia-Manero G, Jabbour E. Pharmacokinetic evaluation of decitabine for the treatment of leukemia. Expert Opin Drug Metab Toxicol. 2011 May;7(5):661-72. doi: 10.1517/17425255.2011.575062. Review. PubMed PMID: 21500965.
2: Bryan J, Borthakur G. Role of rituximab in first-line treatment of chronic lymphocytic leukemia. Ther Clin Risk Manag. 2010 Dec 22;7:1-11. doi: 10.2147/TCRM.S5855. PubMed PMID: 21339937; PubMed Central PMCID: PMC3039008.
3: Bryan J, Jabbour E, Prescott H, Garcia-Manero G, Issa JP, Kantarjian H. Current and future management options for myelodysplastic syndromes. Drugs. 2010 Jul 30;70(11):1381-94. doi: 10.2165/11537920-000000000-00000. Review. PubMed PMID: 20614946.
4: Bryan J, Jabbour E, Prescott H, Kantarjian H. Thrombocytopenia in patients with myelodysplastic syndromes. Semin Hematol. 2010 Jul;47(3):274-80. doi: 10.1053/j.seminhematol.2010.02.006. Review. PubMed PMID: 20620439.